SiDMAP – Metabolomics for Drug Development
Skip to content
Laszlo G. Boros, M.D.
Wai-Nang Paul Lee, M.D.
Targeted Tracer Fate Associations
Precursor/Product Isotope Matching
Targeted Tracer Fate Association Study (TTFAS)
Fill out my
Comments are closed.
SiDMAP’s scientific advisor delivers talk showing single [1,2-13C2]-D-Glucose tracer cross-labels intracellular stearic acid and better traces mechanistic rosiglitazone response than what was obtained with extracellular [U-13C18]-stearate incubation in a separate study using HepG2 cells.
Targeted tracer fate association study finds links among metformin, cholesterol, K-ras and pancreatic cancer growth-control
Combined genomics and targeted tracer fate association approach utilized in characterizing stress response in cancer
SiDMAP Collaboration with University of Utah School of Medicine Published in FASEB Journal
SiDMAP Collaboration With National Cancer Institute To Be Presented at The 2013 World Biotechnology Conference
Global Metabolomics Market to Reach $863.8 Million by 2017, According to a New Report by Global Industry Analysts, Inc.
SiDMAP studies of two Amgen anti-diabetic agents demonstrate mechanisms of glucose homeostatis regulation and energy metabolism.